Chinese Medicine是一本開放獲取期刊,主要發表中醫領域基于證據的、合乎科學的研究和綜述,於2019年總出版58篇論文。Chinese Medicine期刊影響目前已躋身于補充和替代醫學方面期刊前5,亦是少有被SCI收錄的中醫藥期刊。2019年期刊影響因子爲2.960。

面對多種機遇與挑戰,學報經過全面論證與調研,廣泛聽取學者、作者、讀者意見和創新改革建議,於2016年啟動學報編輯部的全面創新改革計劃:學會秘書長王一濤教授出任主編;六名歐美及兩岸四地學者擔任副主編,並邀請包括美國工程院、中國工程院院士在內的二十餘名海內外著名專家擔任高級顧問及中醫藥跨學科多領域的二十餘位海內外學者擔任國際編委。

    改革後的學報編輯部冀能更精確定位學報的投稿領域,並加強維繫五大洲的牢固審稿隊伍,藉以提高稿件處理的科學性和效率,增強編輯、審稿及讀者的交流環節,並逐步提高學報的影響力。

Chinese Medicine is an open access journal publishing evidence-based, scientifically justified research and review papers in all aspects of Chinese medicine. A total of 58 manuscripts were published in Chinese Medicine in 2019. The Journal currently ranks top 5 in the field of Alternative and Complementary Medicine journals and is one of the few SCI indexed journals about Chinese medicine. 2019 Journal Impact Factor is 2.960.

Facing different opportunities and challenges, the Journal shows active response to the renovating opinions from scholars, authors and readers, which inspired and triggered the revolutionary change of the Editorial department as well as publishing policy.Prof. Yitao Wang, the Secretary of ISCM, is the current Editor- in- Chief. Six other outstanding scholars from Europe, America and Asia are serving as Associate Editors. We also invited over twenty domestic and overseas experts as our Senior Advisory board members and another twenty senior researchers as the members of Editorial Board, including those from National Academy of Engineering (USA) and Chinese Academy of Engineering.

The new Editorial team is striving to define our scope more clearly, and strengthen the connection with our reviewers from around the world. The exchange of ideas among editors, reviewers and readers is increasing, so is the influence our Journal in Chinese Medicine as well as in science in general.